Consumer Pricing Science Adviser

The mandate

The Adviser will help executive governance test whether quantitative pricing recommendations are causally credible, robust to response uncertainty and consistent with approved fairness and conduct boundaries. The appointment reviews decision evidence rather than setting prices. There is no line authority, commercial mandate, model approval or operational responsibility.

Two days each week will cover a fortnightly analytical clinic, a monthly outcome review and two scheduled committee sessions. Management supplies approved experiment results, elasticity estimates, cost and risk inputs, constraint definitions and proposed decisions. The Adviser will not run production optimisation, negotiate offers or certify legal compliance.

Challenge will address selection and survivorship bias, confounding, endogenous take-up, price-response heterogeneity, competitor or macro change, extrapolation beyond tested ranges and feedback between price and observed risk. A statistically precise elasticity may still be unusable if the intervention differs from history or vulnerable groups are pooled into an average.

The Adviser will also require post-decision learning: observed response must be compared with the decision distribution, separating forecast error from changed implementation, eligibility or external conditions. This closes the loop without converting advisory review into price ownership.

The committee retains all decisions and accountable owners retain commercial, legal and customer outcomes. Advice will show ranges, distributional effects, uncertainty and what evidence could reverse the recommendation. Where causal identification is inadequate, the Adviser should recommend controlled learning or a simpler boundary rather than manufactured confidence.

At five months, the expected legacy is a pricing-evidence standard, experiment review checklist, heterogeneity view, override record and committee disposition log. Conflicts involving competitors, advisers, data providers, current financial interests or recent pricing work require clearance before confidential decisions are disclosed.

What you will own

• Assess whether elasticity and response estimates identify causal effect or merely reproduce historical selection.
• Challenge extrapolation outside tested populations, price ranges, channels and economic conditions.
• Require heterogeneous effects and distributional consequences to be visible before aggregate recommendations are accepted.
• Review experiments for interference, non-compliance, attrition, power and operational implementation fidelity.
• Test objective functions and constraints for hidden commercial or conduct judgments.
• Frame committee alternatives using outcome ranges, downside and information value of further testing.
• Recommend referral for legal or formal validation work beyond advisory competence.
• Decline price setting, production operation, negotiation and compliance certification.

Candidate qualifications

• Demonstrate senior pricing-science challenge across elasticity, experimentation and constrained decisions.
• Describe a precise response estimate you rejected because causal identification was weak.
• Show how heterogeneity analysis changed a proposed pricing action or protected an affected cohort.
• Evidence an experiment whose implementation failure would have produced a misleading conclusion.
• Explain how you revealed a management preference encoded inside a quantitative objective or constraint.
• Provide an example of advising a committee without owning the commercial decision.
• Identify relationships that could impair neutrality around pricing, competitors or providers.

Working terms and boundaries

• The five-month retainer covers two days weekly, analytical clinics and two planned committee sessions monthly.
• There is no line authority, price mandate, model approval, legal opinion or production responsibility.
• Management owns data assertions, pricing choices, implementation and resulting customer outcomes.
• Additional event attendance requires written reprioritisation or a fee amendment.
• Competitor, provider, advisory and investment conflicts are cleared before restricted access.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 7 October 2026. Mandate reference QNT-ADV-2026-MEX-19.